RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      Membrane proteins in aqueous solutions : from detergents to amphipols

      한글로보기

      https://www.riss.kr/link?id=M14897668

      • 저자
      • 발행사항

        Cham, Switzerland : Springer, [2018] ©2018

      • 발행연도

        2018

      • 작성언어

        영어

      • 주제어
      • DDC

        572.696 판사항(23)

      • ISSN

        2197-5647 (eBook)

      • ISBN

        9783319731469
        3319731467
        9783319731483 (eBook)
        3319731483 (eBook)

      • 자료형태

        단행본(다권본)

      • 발행국(도시)

        스위스

      • 서명/저자사항

        Membrane proteins in aqueous solutions : from detergents to amphipols / Jean-Luc Popot

      • 형태사항

        xxvii, 708 pages : illustrations (some color) ; 27 cm

      • 총서사항

        Biological and medical physics, biomedical engineering, 1618-7210 Biological and medical physics, biomedical engineering

      • 일반주기명

        Includes bibliographical references and index

      • 소장기관
        • 국립중앙도서관 국립중앙도서관 우편복사 서비스
        • 성균관대학교 삼성학술정보관 소장기관정보 Deep Link
      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      목차 (Table of Contents)

      • CONTENTS
      • 1 Membrane Proteins and Their Natural Environment = 1
      • 1.1 Introduction = 1
      • 1.2 Lipid Bilayers = 4
      • 1.3 Membrane Protein Functions = 8
      • CONTENTS
      • 1 Membrane Proteins and Their Natural Environment = 1
      • 1.1 Introduction = 1
      • 1.2 Lipid Bilayers = 4
      • 1.3 Membrane Protein Functions = 8
      • 1.4 Membrane Protein Structure = 13
      • 1.4.1 Modes of Association with the Membrane = 13
      • 1.4.2 Structure of Transmembrane Protein Regions = 15
      • 1.5 Membrane Protein / Lipid Interactions = 22
      • 1.5.1 The Fluid Mosaic Model = 22
      • 1.5.2 Bound Lipids = 25
      • 1.6 Dynamics of Transmembrane Regions and the Function of Membrane Proteins = 32
      • 1.6.1 Bacteriorhodopsin = 32
      • 1.6.2 The Nicotinic Acetylcholine Receptor = 36
      • 1.6.3 The Sarcoplasmic Reticulum Calcium Pump = 44
      • 1.7 Synthesis of Membrane Proteins = 48
      • 1.7.1 Natural Biosynthesis = 48
      • 1.7.2 Overexpression = 50
      • References = 51
      • 2 Extracting Membrane Proteins from Their Native Environment = 59
      • 2.1 Introduction = 59
      • 2.2 Detergents = 60
      • 2.2.1 Chemical Structure = 60
      • 2.2.2 Physical-Chemical Properties = 62
      • 2.3 Solubilizing Membrane Proteins with Detergents = 65
      • 2.3.1 Solubilizing Biological Membranes with Detergents = 65
      • 2.3.2 Membrane Protein / Detergent Complexes = 68
      • 2.4 Why Are Membrane Proteins Unstable in Detergent Solutions? = 70
      • 2.4.1 Instability of Detergent-Solubilized Membrane Proteins Is a General Phenomenon = 70
      • 2.4.2 A Field Case : Inactivation of the Cytochrome b6f Complex by Detergents = 72
      • 2.4.3 The Dissociating Character of Detergents as a Major Cause of Membrane Protein Inactivation = 76
      • 2.4.4 Detergent-Induced Conformational Alterations = 80
      • 2.5 Solutions to the Instability Problem = 81
      • 2.5.1 Making Detergents Less Aggressive = 81
      • 2.5.2 Making Membrane Proteins More Resistant = 84
      • 2.5.3 What About Keeping Membrane Proteins Water-Soluble Without Using Detergents? = 87
      • References = 88
      • 3 Alternatives to Detergents for Handling Membrane Proteins in Aqueous Solutions = 97
      • 3.1 Introduction = 97
      • 3.2 Bicelles = 99
      • 3.2.1 The Formation and Phase Diagram of Bicelles and Their Use in Membrane Protein NMR Spectroscopy = 99
      • 3.2.2 Bicelles and Membrane Protein Crystallography = 103
      • 3.2.3 Other Applications of Bicelles in Membrane Biology = 104
      • 3.3 Nanodiscs = 105
      • 3.3.1 High-Density Lipoproteins = 105
      • 3.3.2 The Formation and Structure of Nanodiscs = 107
      • 3.3.3 The Empty Nanodisc = 109
      • 3.3.4 Membrane Protein/Nanodisc Complexes = 111
      • 3.3.5 Nanodisc-Based Investigations of Membrane Proteins = 115
      • 3.4 Amphipathic Peptides = 118
      • 3.4.1 Peptitergents = 120
      • 3.4.2 Lipopeptide Detergents = 120
      • 3.4.3 Designer Peptide Surfactants (Peptergents) = 121
      • 3.4.4 Stabilizing Membrane Proteins by Complexation with Saposin A ("Picodiscs," "Sap A discs," "Salipro® Nanoparticles") = 123
      • 3.4.5 Peptide-Based Nanodiscs = 127
      • 3.5 Fluorinated Surfactants = 128
      • 3.5.1 Background = 128
      • 3.5.2 Novel Structures of Fluorinated Surfactants = 130
      • 3.5.3 Applications of Fluorinated Surfactants = 131
      • 3.6 Nonconventional Surfactants Used for Handling Membrane Proteins in Aqueous Solutions : An Overview = 133
      • References = 135
      • 4 Chemical Structure, Synthesis, and Physical-Chemical Properties of Amphipols = 151
      • 4.1 Introduction = 151
      • 4.2 Amphipol Chemical Structure and Synthesis = 152
      • 4.2.1 Polyacrylate-Based Amphipols with Carboxylates as Their Hydrophilic Moieties = 153
      • 4.2.2 Other Ionic Amphipols = 162
      • 4.2.2.1 Sulfonated Amphipols = 162
      • 4.2.2.2 Phosphorylcholine-Based Amphipols = 162
      • 4.2.2.3 PMAL Series = 163
      • 4.2.2.4 Styrene-Maleic Acid Copolymer = 163
      • 4.2.2.5 Hydrophobically Grafted Poly-γ-Glutamic Acid (APG) = 164
      • 4.2.3 Non-ionic Amphipols = 165
      • 4.2.3.1 THAM-Based Non-ionic Amphipols = 165
      • 4.2.3.2 Glucose-Based Non-ionic Amphipols (NAPols) = 167
      • 4.2.3.3 NVoy = NV 10 = 169
      • 4.3 Self-Association Behavior of Amphipols in Aqueous Solutions = 169
      • 4.3.1 Formation, Structure, and Dynamics of A8-35 Particles = 170
      • 4.3.1.1 Critical Association Concentration = 170
      • 4.3.1.2 The Size, Shape, and Organization of A8-35 Particles = 176
      • 4.3.1.2.1 Mass and Dispersity of Individual A8-35 Molecules = 176
      • 4.3.1.2.2 Homogeneity, Mass, and Size of A8-35 Particles = 178
      • 4.3.1.2.3 Shape and Internal Organization of A8-35 Particles = 183
      • 4.3.1.2.4 Dynamics of A8-35 Particles = 187
      • 4.3.1.2.5 Data Pertaining to the Phase Diagram of A8-35 = 191
      • 4.3.2 Solution Properties of Other Amphipols = 192
      • 4.4 Labeled and Functionalized Amphipols = 198
      • 4.4.1 Synthesis of Labeled or Tagged Derivatives of A8-35 and A8-75 = 198
      • 4.4.2 Solution Behavior of Labeled or Tagged Derivatives of A8-35 and A8-75 = 203
      • 4.5 Protocol 4.1 : Synthesis of A8-35 = 205
      • 4.5.1 Preparation and Characterization of the PAA Precursor = 205
      • 4.5.2 Hydrophobic Modification of the PAA Precursor = 207
      • 4.5.3 Purification of A8-35 = 208
      • 4.5.4 Determination of the Chemical Composition of the Final Product = 208
      • 4.6 Annexes = 210
      • 4.6.1 Annex 4.1. Determining and Expressing the Average Mass and Dispersity of Polymers = 210
      • 4.6.1.1 The Origin of Dispersity = 210
      • 4.6.1.2 How Can Size Dispersity Be Limited? = 211
      • 4.6.1.3 Expressing the Average Mass and Dispersity of Polymers = 213
      • 4.6.1.4 Determining the Average Mass and Dispersity of Polymers = 214
      • 4.6.1.5 Calibration of Size Exclusion Chromatography Columns = 214
      • 4.6.2 Annex 4.2. Kinetics of Conventional Radical Polymerization and Origin of Size Dispersity = 216
      • 4.6.3 Annex 4.3. Expression of the Instantaneous and Cumulative Average Degree of Polymerization in Conventional Radical Polymerization = 217
      • 4.6.4 Annex 4.4. How to Control the Size of Polymers Obtained by Radical Polymerization? = 218
      • 4.6.4.1 Telomerization (Chain Transfer) = 218
      • 4.6.4.2 Controlled / Living Radical Polymerization (CRP) = 219
      • 4.6.5 Annex 4.5. Polymer Topology and How to Control It = 222
      • 4.6.5.1 Polymer Topology = 222
      • 4.6.5.2 Polymer Composition (Microstructure) = 223
      • 4.6.6 Annex 4.6. Functionalizing Polymers = 225
      • 4.6.6.1 General Considerations = 225
      • 4.6.6.2 Possible Applications of Controlled Radical Polymerization to the Chemistry of Amphipols = 227
      • References = 227
      • 5 Formation and Properties of Membrane Protein/Amphipol Complexes = 237
      • 5.1 Introduction = 237
      • 5.2 Forming Membrane Protein/Amphipol Complexes = 238
      • 5.2.1 Transferring Native Membrane Proteins from Detergent Solution to Amphipols = 252
      • 5.2.2 Direct Extraction of Proteins from Membranes = 259
      • 5.2.2.1 Styrene-Maleic Acid Copolymers = 260
      • 5.2.2.2 Can Membrane Proteins Be Directly Solubilized Using Polyacrylate-Based Amphipols? = 261
      • 5.2.3 Folding Membrane Proteins in Amphipols = 265
      • 5.3 Composition, Organization, Dynamics, and Solution Properties of Membrane Protein/Amphipol Complexes = 266
      • 5.3.1 Particle Composition = 273
      • 5.3.1.1 Amphipol vs. Detergent Binding = 274
      • 5.3.1.2 Lipid Binding = 275
      • 5.3.2 Particle Size and Organization = 279
      • 5.3.3 Protein/Polymer Interactions = 283
      • 5.4 Functionality of Amphipol-Trapped Membrane Proteins = 286
      • 5.5 Biochemical Stability of Amphipol-Trapped Membrane Proteins = 290
      • 5.6 Membrane Protein Dynamics and the Effects of Amphipols on Stability and Function = 296
      • 5.6.1 Functional Observations = 297
      • 5.6.2 Molecular Dynamics Simulations = 303
      • 5.7 Transferring Membrane Proteins from Amphipols to Other Environments = 306
      • 5.8 Conclusion = 310
      • 5.9 Protocols = 311
      • 5.9.1 Protocol 5.1. Transferring MPs from Detergents to APols = 311
      • 5.9.1.1 Preparation of a Stock Solution of APols = 311
      • 5.9.1.2 Determination of the Protein Concentration = 311
      • 5.9.1.3 Determination of the Optimal MP/APol Mass Ratio = 312
      • 5.9.1.4 Detergent Removal = 312
      • 5.9.1.5 Identification of the Optimal MP/APol Ratio = 313
      • 5.9.2 Protocol 5.2. Determining the Amount of MP-Bound APol = 314
      • 5.9.2.1 Why Is It Preferable to Express the Amount of APols Bound per MP in Mass Rather Than as a Number of Molecules? = 315
      • 5.9.2.2 How to Estimate A Priori the Likely Amount of APols Bound per MP Based on Structural Data? = 315
      • 5.9.2.3 How to Experimentally Measure the Quantity of APols Bound per MI39 = 316
      • 5.9.3 Protocol 5.3. Transferring a MP from A8-35 to Nanodiscs = 319
      • 5.9.3.1 Exchange of A8-35 for DDM = 319
      • 5.9.3.2 Reconstitution into Nanodiscs = 320
      • References = 322
      • 6 Amphipol-Assisted Folding of Membrane Proteins = 333
      • 6.1 Introduction = 333
      • 6.2 Context : Existing Approaches to Folding Membrane Proteins In Vitro = 334
      • 6.3 Amphipol-Assisted Folding of Membrane Proteins = 338
      • 6.3.1 Which Membrane Proteins Have Been Folded in Amphipols and How = 338
      • 6.3.1.1 Amphipol-Assisted Folding of α-Helical Membrane Proteins = 339
      • 6.3.1.1.1 Folding of BR in A8-35 = 339
      • 6.3.1.1.2 A8-35-Assisted Folding of GPCRs = 343
      • 6.3.1.1.3 Folding of α-Helical Membrane Proteins in Non-ionic Amphipols = 345
      • 6.3.1.2 Amphipol-Assisted Folding of β-Barrel Membrane Proteins = 346
      • 6.3.1.2.1 Folding of OmpA and FomA in A8-35 = 347
      • 6.3.1.2.2 Folding of tOmpA, OmpT, and PagP = 348
      • 6.3.1.2.3 Kinetics and Thermodynamics of Folding OmpA in A8-35 = 349
      • 6.3.2 Why Are Amphipols a Good Medium for Membrane Protein Folding? = 350
      • 6.3.3 Challenges and Prospects = 353
      • 6.4 Protocol 6.1. Amphipol-Assisted Folding of Membrane Proteins = 354
      • 6.4.1 Solubilization and Purification of MPs in Denaturing Conditions = 354
      • 6.4.2 Renaturation of α-Helical MPs in APols = 355
      • 6.4.3 Renaturation of β-Barrel MPs in APols = 356
      • 6.4.4 Completing the Renaturation = 356
      • References = 356
      • 7 Amphipol-Assisted Cell-Free Expression of Membrane Proteins = 361
      • 7.1 Introduction = 361
      • 7.2 Context : Cell-Free Expression of Membrane Proteins = 363
      • 7.3 Cell-Free Expression of Membrane Proteins Using Amphipols and Other Amphipathic Polymers = 365
      • 7.4 Conclusions and Perspectives = 373
      • 7.5 Protocol 7.1 : Cell-Free Expression of Membrane Proteins in the Presence of Non-ionic Amphipols = 375
      • 7.5.1 Introduction = 375
      • 7.5.2 Protocol = 375
      • References = 376
      • 8 Optical Spectroscopy of Membrane Protein / Amphipol Complexes = 381
      • 8.1 Introduction = 381
      • 8.2 Optical Spectroscopy Studies of Amphipols and Membrane Protein / Amphipol Complexes = 382
      • 8.2.1 Circular Dichroism and Synchrotron Radiation Circular Dichroism = 391
      • 8.2.2 Infrared and Raman Spectroscopy = 394
      • 8.2.3 Fluorescence Spectroscopy = 397
      • 8.3 Conclusions and Prospects = 400
      • References = 401
      • 9 Solution Studies of Membrane Protein / Amphipol Complexes = 405
      • 9.1 Introduction = 406
      • 9.2 Overview of the Literature = 409
      • 9.3 A Walk Through Selected Solution Studies = 410
      • 9.3.1 Sucrose Gradient Rate Zonal Ultracentrifugation = 411
      • 9.3.2 Size Exclusion Chromatography = 417
      • 9.3.3 Blue-Native Polyacrylamide Gel Electrophoresis = 419
      • 9.3.4 Chemical Cross-Linking = 421
      • 9.3.5 Electron Resonance Spectroscopy = 421
      • 9.3.6 Determination of Rotational Correlation Times by Solution NMR = 422
      • 9.3.7 Analytical Ultracentrifugation = 423
      • 9.3.8 Small-Angle X-ray and Neutron Solution Scattering = 426
      • 9.3.8.1 Introduction = 426
      • 9.3.8.2 Small-Angle Neutron Scattering = 432
      • 9.3.8.3 Small-Angle X-ray Scattering = 437
      • 9.3.9 Dynamic Light Scattering = 438
      • 9.4 Conclusions and Prospects = 439
      • 9.5 Protocols = 440
      • 9.5.1 Protocol 9.1 : Analytical Ultracentrifugation of Membrane Protein / Amphipol Complexes = 440
      • 9.5.1.1 Introduction = 440
      • 9.5.1.2 Instrumentation = 441
      • 9.5.1.3 Designing the Samples and Experiments = 441
      • 9.5.1.4 Compiling the Parameters That Will Be Required for the Analysis = 442
      • 9.5.1.5 Running SV Experiments = 442
      • 9.5.1.6 c(s) Analysis = 442
      • 9.5.2 Protocol 9.2 : Size Exclusion Chromatography Analysis of Membrane Protein / Amphipol Complexes = 444
      • 9.5.2.1 Introduction = 444
      • 9.5.2.2 Biochemistry = 444
      • 9.5.2.3 Size Exclusion Chromatography System = 445
      • 9.5.2.4 Buffers = 445
      • 9.5.2.5 Protocol = 446
      • 9.5.2.6 Commented Examples = 446
      • References = 448
      • 10 Nuclear Magnetic Resonance Studies of Amphipol-Trapped Membrane Proteins = 453
      • 10.1 Introduction = 453
      • 10.2 Context : Solution NMR Studies of Membrane Proteins = 455
      • 10.2.1 Producing the Protein = 455
      • 10.2.2 Membrane Protein / Surfactant Complexes Suitable for Solution NMR = 456
      • 10.3 Solution NMR Studies of Amphipol-Trapped Membrane Proteins = 461
      • 10.3.1 Validating and Developing the Methodology = 463
      • 10.3.1.1 Validating the Use of Amphipols for sNMR and Resolution of the Spectra as Compared with Those Obtained in Detergent Solutions = 465
      • 10.3.1.2 Mapping Membrane Protein / Amphipol Interactions by NMR = 469
      • 10.3.2 Developing pH-Insensitive and Fully Deuterated Amphipols = 473
      • 10.3.2.1 pH-Insensitive Amphipols and Their Use in sNMR = 473
      • 10.3.2.2 Deuterated Amphipols = 479
      • 10.3.3 Biologically Oriented Studies = 482
      • 10.3.3.1 Dynamics of the Transmembrane β-Barrel of OmpX = 483
      • 10.3.3.2 Conformation of LTB4 Bound to the BLT2 Leukotriene Receptor = 483
      • 10.3.3.3 Preliminary Studies of Chlamydia trachomatis MOMP and Two Melanocortin Receptors = 488
      • 10.4 Challenges and Prospects = 488
      • References = 490
      • 11 Amphipols and Membrane Protein Crystallization = 497
      • 11.1 Introduction = 497
      • 11.2 Context : Classical and Less Classical Approaches to Crystallizing Membrane Proteins = 498
      • 11.2.1 Factors Contributing to the Steady Growth of the Number of MP Structures Solved = 498
      • 11.2.2 The Formation of Membrane Protein Crystals = 500
      • 11.2.2.1 Crystals Formed in Detergent Solutions = 503
      • 11.2.2.2 Forming Crystals in Lipid Three-Dimensional Phases = 506
      • 11.3 Using Amphipols for Crystallizing Membrane Proteins = 508
      • 11.3.1 Crystallization of Cytochrome bc1 / A8-35 Complexes in Aqueous Solutions : Failures and Partial Successes and the Possible Reasons Underlying Them = 509
      • 11.3.2 Using Amphipols as a Vehicle to Crystallize Membrane Proteins in Meso = 516
      • 11.3.3 Challenges and Prospects = 522
      • 11.4 Protocol: Crystallizing bc1 / A8-35 / Detergent Complexes from Aqueous Solutions = 523
      • 11.4.1 Pre-crystallization = 523
      • 11.4.2 Crystallization of Ternary Protein / Amphipol/Detergent Complexes = 524
      • References = 525
      • 12 The Use of Amphipols for Electron Microscopy = 533
      • 12.1 Introduction = 533
      • 12.2 Context : Electron Microscopy Studies of Membrane Proteins = 534
      • 12.2.1 The Various Approaches to Studying Membrane Proteins by Electron Microscopy = 534
      • 12.2.2 Single-Particle Electron Microscopy Studies of Biological Molecules : The Basics = 535
      • 12.2.3 Single-Particle Cryo-EM Studies of Biological Molecules : The Resolution Revolution = 538
      • 12.2.4 Single-Particle Electron Microscopy Studies of Membrane Proteins = 540
      • 12.3 The Use of Amphipols for Membrane Protein Electron Microscopy Studies = 541
      • 12.3.1 The Early Years : 1998-2008 = 549
      • 12.3.2 Recent Studies of Negatively Stained MP / APol Complexes (2011-Present) = 554
      • 12.3.2.1 Conclusions from Negative-Stain Studies = 561
      • 12.3.3 Cryo-EM Studies of MP / APol Complexes (2011-Present) = 562
      • 12.3.4 Conclusions and Perspectives = 573
      • 12.3.4.1 Solution Properties of the Samples = 573
      • 12.3.4.2 Imaging = 574
      • 12.3.4.3 Perspectives, Suggestions, and Speculations = 577
      • 12.4 Protocol 12.1 : Preparation of Amphipol-Trapped Membrane Proteins for Cryo-EM Studies = 579
      • 12.4.1 Introduction = 579
      • 12.4.2 Vectors and Cell Lines = 580
      • 12.4.3 Buffers = 580
      • 12.4.4 Protocol = 581
      • References = 583
      • 13 Amphipol-Mediated Immobilization of Membrane Proteins and Its Applications = 591
      • 13.1 Introduction = 591
      • 13.2 Immobilization of Membrane Proteins Using Biotinylated Amphipols and Its Applications = 595
      • 13.2.1 Validation of the Approach Using Biotinylated A8-35 = 595
      • 13.2.2 Multiplexing = 600
      • 13.2.3 Using Ionic vs. Non-ionic Biotinylated Amphipols for Phage Display Selection of Membrane Protein Binders = 604
      • 13.3 Alternative Tags = 607
      • 13.3.1 Polyhistidine-Tagged A8-35 = 608
      • 13.3.2 Imidazole-Tagged Amphipols = 611
      • 13.3.3 Oligonucleotide-Tagged Amphipol = 613
      • 13.3.4 Sulfide- and Sulfhydryl-Tagged Amphipols = 615
      • 13.4 Other Applications of Tagged Amphipols = 616
      • 13.5 Protocol 13.1. Amphipol-Mediated Immobilization of Membrane Proteins for Surface Plasmon Resonance Experiments = 617
      • 13.5.1 Experimental Setup = 617
      • 13.5.2 Preparation of Samples = 618
      • 13.5.3 Measurements = 618
      • References = 619
      • 14 The Use of Amphipols in Mass Spectrometry = 625
      • 14.1 Introduction = 625
      • 14.2 MALDI-TOF Studies = 633
      • 14.3 Electrospray Ionization-Mass Spectrometry Studies = 636
      • 14.3.1 Membrane Protein / Amphipol Complexes Are Amenable to Electrospray Mass Spectrometry = 636
      • 14.3.2 Amphipols, ESI-MS, and Oligomeric Membrane Proteins = 640
      • 14.3.3 Interactions of Detergents vs. Amphipols with Membrane Proteins as Probed by Mass Spectrometry = 641
      • 14.3.4 Can Amphipols Better Suited to ESI-MS Be Developed? = 643
      • 14.4 Proteomics = 644
      • 14.5 Protocol 14.1 : Characterization of Amphipol-Trapped Membrane Proteins by Electrospray Ionization-Ion Mobility Spectrometry-Mass Spectrometry = 648
      • 14.5.1 Introduction = 648
      • 14.5.2 Materials = 648
      • 14.5.3 Protocol = 649
      • 14.5.4 Outlook = 654
      • References = 655
      • 15 Biomedical Applications = 659
      • 15.1 Introduction = 659
      • 15.2 Using Amphipols to Formulate a Subunit Vaccine Against Chlamydia trachomatis = 661
      • 15.2.1 Background = 661
      • 15.2.2 Developing an Amphipol-Based Vaccine = 664
      • 15.2.3 How Could Amphipols Help in Formulating More Efficient Vaccines? = 669
      • 15.3 Uptake of A8-35 and a Passenger Peptide by Cells in Culture = 672
      • 15.4 Biodistribution and Elimination of Amphipols Following Injection in Mice = 674
      • References = 678
      • Final Comments = 683
      • Index = 687
      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼